<DOC>
	<DOCNO>NCT02019381</DOCNO>
	<brief_summary>Recently two distinguish committee , Institute Medicine ( IOM ) The Endocrine Society propose different intake guideline Calcium Vitamin D. We wish compare effect calcium metabolism bone turnover . We propose one year randomize double blind study .</brief_summary>
	<brief_title>Study Effects Vitamin D Calcium Supplementation Tolerable Upper Limit Doses Calcium Metabolism .</brief_title>
	<detailed_description>The specific aim study proposal determine follow : 1 . To compare two different intake guideline Calcium Vitamin D Supplementation recommend tolerable upper limit serum urinary calcium white postmenopausal Women . 2 . Compare effect mention two intake guideline Vitamin D metabolism [ 25 ( OH ) D , 1,25 ( OH ) 2D ] bone turnover . Participants randomly assign Group A Group B base different dosage study medication . Group A : 10,000 IU ( International Units ) Vitamin D + Placebo ( sugar pill ) 600IU Vitamin D + Two pill Calcium contain 600mg calcium . Group B : 600 IU Vitamin D + Placebo ( sugar pill ) 10,000 IU Vitamin D + Two pill Calcium contain 600mg calcium . In addition calcium supplement , guide include approximately 800mg calcium daily diet . At visit 2 , fast blood spot urine collect . A urinal dispensed collection 24-hour urine urinary calcium bring next day . Study medication dispense participant ask discard unused medication bring study medication next study visit . Visit 3 , 4 , 5 , 6 essentially visit 2 , subject return unused study medication give new tablet visit . Except visit 6 study medication dispense , collect previous supply . Food frequency questionnaire fill initial visit final visit . Diet assess use 3-day diet history form Nutrition Pro analysis software . Patients ask refrain take Vitamin D supplement continue usual calcium intake .</detailed_description>
	<mesh_term>Delusions</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1 . Healthy White woman age 50 old postmenopausal least 2 year ( i.e . absence menstrual period period 24 month ) . 2 . Willingness discontinue selfadministration vitamin D calcium supplement . Participants must least three month supplement start study . 3 . Willingness take study medication participate study one year . 4 . Written inform Consent Signed . 5 . Patients hypertension diabetes stable last three month . 1 . History hypercalciuria ( 24hour urinary calcium excretion &gt; 250 mg ) , hypercalcemia ( serum calcium &gt; 10.6 ) , nephrolithiasis active sarcoidosis exclude . 2 . Serum 25hydroxyvitamin D level &gt; 80 nmol/L history primary hyperparathyroidism . 3 . Dietary calcium intake &gt; 2000mg/day exclude 4 . Use medication influence bone vitamin D metabolism ( e.g . anticonvulsant medication , glucocorticoid , Highly Active AntiRetroviral Therapy [ AIDS treatment ] , antirejection medication , chronic use steroid , high dose diuretic ) 5 . Treatment Hormone replacement therapy , Selective Estrogen Receptor Modulators , Calcitonin , Parathyroid hormone , androgen , bisphosphonates , phosphate anabolic steroid 6 month prior study . 6 . Use systemic steroid ( oral intravenous ) within last year average dose 5mg/day oral prednisone equivalent period three month prior screen . 7 . Chronic medical illness include Chronic liver disease , uncontrolled diabetes mellitus ; recent history myocardial infarction heart failure ; newly diagnose active malignancy ; uncontrolled hypertension ; obesity ( BMI &gt; 35 kg/m2 ) ; malabsorption , anemia , leukemia , hematologic abnormality ; lupus , rheumatoid arthritis , sarcoidosis , rheumatologic disease ; chronic kidney disease , metabolic bone disease . 8 . Unexplained weight loss &gt; 15 % previous year history anorexia nervosa 9 . &gt; 1 pack per day tobacco use &gt; 2 alcoholic beverage per day 10 . Unwillingness forego selfadministration vitamin D calciumcontaining supplement . 11 . Participation another investigational trial past 30 day prior screen evaluation 12 . Significant deviation normal medical history , physical examination , laboratory test evaluate primary investigator . 13 . Patients unstable hypertension diabetes .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>